Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
28<br />
<strong>Solvay</strong> Global Annual Report 2005<br />
The “Electrochemistry<br />
and Fluorinated<br />
Products” cluster<br />
Results of the electrolysis-derived<br />
activities improved in 2005.<br />
Caustic Soda prices remained<br />
buoyant throughout 2005, thanks<br />
to excellent world demand, in particular<br />
in the paper and aluminium<br />
sectors. Price prospects for early<br />
2006 are good.<br />
In Allyls, demand is increasingly<br />
catching up with globally available<br />
supplies. The market, which was<br />
in balance in 2005, will be tight in<br />
2006. As a result, the fi nancial<br />
performance of this activity<br />
improved in 2005. <strong>Solvay</strong> is also<br />
developing a new and innovative<br />
technology which will enable it to<br />
respond to future market demands.<br />
2005 was a better year for<br />
Fluorinated Products,<br />
with earnings up signifi cantly from<br />
earlier years and ahead of forecasts.<br />
These good results were<br />
attained, despite the rising cost of<br />
the production inputs, thanks<br />
mainly to the very good performance<br />
of refrigeration products.<br />
Activity was also sustained in<br />
Specialties and Inorganic products<br />
for other applications, in certain of<br />
which production capacity limits<br />
have been reached. To meet<br />
the expected growth in these<br />
products the Group decided in<br />
2005 to establish fl uorinated<br />
specialties production units at<br />
Onsan (South Korea).<br />
The fi rst unit is due to come into<br />
service in early 2007 to serve Asia’s<br />
rapidly expanding automobile and<br />
electronics markets. The Onsan<br />
units will use technologies that<br />
have already proven their technical,<br />
safety and environmental capacities<br />
at other <strong>Solvay</strong> Fluor sites.<br />
The total capital expenditure is of<br />
the order of EUR 50 million.<br />
Prospects for 2006 and beyond<br />
are good, with stronger markets<br />
for traditional products in Europe,<br />
development of new applications<br />
and the forthcoming start-up of<br />
Specialty units in Asia.<br />
Chemicals <strong>Sector</strong><br />
The “Oxygen”<br />
cluster: Peroxygens,<br />
Detergents and<br />
Caprolactones<br />
The Hydrogen Peroxide<br />
market has grown well across<br />
the world and more especially in<br />
Europe, Mercosur and South-East<br />
Asia. Rising energy costs have<br />
placed margins under pressure.<br />
After successful testing on a pilot<br />
manufacturing scale at Povoa<br />
(Portugal), <strong>Solvay</strong>’s new hydrogen<br />
peroxide production process, one<br />
of the most effi cient in the world,<br />
was installed at Deer Park (Texas),<br />
increasing capacity by 50% to<br />
118 kilotonnes, and at Voikkaa<br />
in Finland, doubling capacity<br />
to 85 kilotonnes. These have<br />
confi rmed the feasibility of major<br />
capacity expansions at minimum<br />
investment cost.<br />
A partnership was created with<br />
BASF and Dow in connection with<br />
their project to produce propylene<br />
oxide through a new process using<br />
hydrogen peroxide. <strong>Solvay</strong> has begun<br />
building in Antwerp (Belgium)<br />
a giant manufacturing unit using<br />
its high-yield technology, which<br />
will produce 230 kilotonnes a year<br />
of hydrogen peroxide on a single<br />
line in 2008.